BR112014017630A8 - Métodos para a determinação de presença e/ou da quantidade de um antígeno - Google Patents

Métodos para a determinação de presença e/ou da quantidade de um antígeno

Info

Publication number
BR112014017630A8
BR112014017630A8 BR112014017630A BR112014017630A BR112014017630A8 BR 112014017630 A8 BR112014017630 A8 BR 112014017630A8 BR 112014017630 A BR112014017630 A BR 112014017630A BR 112014017630 A BR112014017630 A BR 112014017630A BR 112014017630 A8 BR112014017630 A8 BR 112014017630A8
Authority
BR
Brazil
Prior art keywords
antigen
antibody
determining
methods
sample
Prior art date
Application number
BR112014017630A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112014017630A2 (cg-RX-API-DMAC7.html
Inventor
Stubenrauch Kay-Gunnar
Wessels Uwe
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR112014017630A2 publication Critical patent/BR112014017630A2/pt
Publication of BR112014017630A8 publication Critical patent/BR112014017630A8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
BR112014017630A 2012-02-01 2013-01-29 Métodos para a determinação de presença e/ou da quantidade de um antígeno BR112014017630A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12153457 2012-02-01
EP12182505 2012-08-31
PCT/EP2013/051604 WO2013113663A1 (en) 2012-02-01 2013-01-29 Method for the detection of a binding partner of a multispecific binder

Publications (2)

Publication Number Publication Date
BR112014017630A2 BR112014017630A2 (cg-RX-API-DMAC7.html) 2017-06-20
BR112014017630A8 true BR112014017630A8 (pt) 2017-07-11

Family

ID=47624068

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014017630A BR112014017630A8 (pt) 2012-02-01 2013-01-29 Métodos para a determinação de presença e/ou da quantidade de um antígeno

Country Status (10)

Country Link
US (3) US9945869B2 (cg-RX-API-DMAC7.html)
EP (1) EP2810074B1 (cg-RX-API-DMAC7.html)
JP (3) JP2015507193A (cg-RX-API-DMAC7.html)
KR (1) KR20140128314A (cg-RX-API-DMAC7.html)
CN (2) CN104105966B (cg-RX-API-DMAC7.html)
BR (1) BR112014017630A8 (cg-RX-API-DMAC7.html)
CA (1) CA2859268A1 (cg-RX-API-DMAC7.html)
MX (1) MX349661B (cg-RX-API-DMAC7.html)
RU (1) RU2620563C2 (cg-RX-API-DMAC7.html)
WO (1) WO2013113663A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140128314A (ko) 2012-02-01 2014-11-05 에프. 호프만-라 로슈 아게 다중특이적 결합제의 결합 파트너 검출 방법
EP2872893B1 (en) 2012-07-13 2017-03-29 F. Hoffmann-La Roche AG Method for the detection of a multispecific antibody
JP6446044B2 (ja) * 2013-11-05 2018-12-26 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 結合分子の存在下で被検体の総量および/または総濃度を決定するための方法、ならびにそれに関係するキット、組成物および使用
CN104109197B (zh) * 2013-11-13 2017-05-10 叶森 一种双识别抗体片段的制备方法及其应用
CN108139394B (zh) * 2015-10-02 2020-10-30 豪夫迈·罗氏有限公司 用于确定同时结合的基于细胞的fret测定法
MA43028B1 (fr) 2015-10-02 2021-09-30 Hoffmann La Roche Anticorps bispécifiques pour pd1 et tim3
ES2927977T3 (es) * 2017-02-06 2022-11-14 Biotempt Bv Moduladores peptídicos de la interacción entre el péptido C humano y el receptor de elastina humana para uso terapéutico
KR102461885B1 (ko) 2017-04-03 2022-11-03 에프. 호프만-라 로슈 아게 항-pd-1 항체와 돌연변이 il-2 또는 il-15의 면역접합체
CA3052532A1 (en) 2017-04-05 2018-10-11 F. Hoffmann-La Roche Ag Bispecific antibodies specifically binding to pd1 and lag3
JP7370322B2 (ja) 2018-06-04 2023-10-27 中外製薬株式会社 複合体を検出する方法
EP3969907B1 (en) * 2019-05-13 2025-09-24 F. Hoffmann-La Roche AG Interference-suppressed pharmacokinetic immunoassay
WO2022065052A1 (ja) * 2020-09-24 2022-03-31 株式会社Jvcケンウッド 捕捉用抗体、固相担体、検出用抗体、固相担体粒子、並びに検出対象物質の測定キット及び測定方法
CN117805397A (zh) * 2024-02-29 2024-04-02 军科正源(北京)药物研究有限责任公司 检测游离vegf的方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219730A (en) 1982-09-28 1993-06-15 New York University Idiotype-anti-idiotype immunoassay
US4828981A (en) 1983-08-24 1989-05-09 Synbiotics Corporation Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
EP0170302A1 (fr) 1984-06-27 1986-02-05 l'Association internationale à but scientifique, dite: Institut international de pathologie cellulaire et moléculaire Procédé de dosage immunologique d'une substance dans un échantillon liquide au moyen d'anticorps anti-idiotypiques
US5238808A (en) 1984-10-31 1993-08-24 Igen, Inc. Luminescent metal chelate labels and means for detection
WO1987002778A1 (en) 1985-10-22 1987-05-07 Cooper-Lipotech Solid-phase liposome immunoassay system
DE68928994T2 (de) 1988-11-03 1999-12-16 Igen International, Inc. Elektrochemilumineszente testverfahren
US5068088A (en) 1988-11-03 1991-11-26 Igen, Inc. Method and apparatus for conducting electrochemiluminescent measurements
IL100866A (en) 1991-02-06 1995-10-31 Igen Inc Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets
DE69332377T2 (de) 1992-07-13 2003-07-03 Bionebraska, Inc. Verfahren zur modifizierung rekombinanter polypeptide
JPH097096A (ja) 1995-06-20 1997-01-10 Alpine Electron Inc 緊急車両接近時の報知方法
JPH0975096A (ja) * 1995-09-14 1997-03-25 Snow Brand Milk Prod Co Ltd ラクトフェリンの測定法
DE69828642T2 (de) 1997-11-21 2005-12-29 Inverness Medical Switzerland Gmbh Verbesserungen an oder in bezug auf verschiebungstests
JPH11352129A (ja) * 1998-06-04 1999-12-24 Mizuho Medeii:Kk 検出装置及び検出方法
US6753189B1 (en) 1998-06-04 2004-06-22 Mizuho Medy Co., Ltd. Detection apparatus and method for the same
CN100399030C (zh) * 1999-11-16 2008-07-02 杰南技术公司 用于vegf的elisa
GB0007088D0 (en) * 2000-03-23 2000-05-17 Torsana A S Detection of immunological memory determining the position of loci of pathologyand therapeutic t-cell conjugates
US6984494B2 (en) 2000-08-15 2006-01-10 Genentech, Inc. Analytical method
US7341837B2 (en) * 2003-09-02 2008-03-11 Lawton Robert L Soluble analyte detection and amplification
WO2006096697A2 (en) * 2005-03-08 2006-09-14 Tanox, Inc. Methods for determining the bivalency of protein and antibody therapeutics
US7494776B2 (en) * 2005-07-07 2009-02-24 Beckman Coulter, Inc. Labeled complementary oligonucleotides to detect oligonucleotide-linked ligands
SG164379A1 (en) 2005-07-21 2010-09-29 Genmab As Potency assays for antibody drug substance binding to an fc receptor
CN101268372A (zh) * 2005-07-21 2008-09-17 根马布股份公司 与fc受体结合的抗体药物的药效测定
DK2457929T3 (en) * 2006-10-04 2016-09-05 Genentech Inc Elisa vegf
EP1917854A1 (en) 2006-11-06 2008-05-07 F. Hoffmann-La Roche Ag Method for producing anti idiotypic antibodies
US8242247B2 (en) 2007-12-21 2012-08-14 Hoffmann-La Roche Inc. Bivalent, bispecific antibodies
US8227577B2 (en) 2007-12-21 2012-07-24 Hoffman-La Roche Inc. Bivalent, bispecific antibodies
US20090162359A1 (en) 2007-12-21 2009-06-25 Christian Klein Bivalent, bispecific antibodies
US9266967B2 (en) 2007-12-21 2016-02-23 Hoffmann-La Roche, Inc. Bivalent, bispecific antibodies
EP2297209A4 (en) 2008-06-03 2012-08-01 Abbott Lab IMMUNOGLOBULINS WITH TWO VARIABLE DOMAINS AND USES THEREOF
US20110195524A1 (en) * 2008-10-07 2011-08-11 Mats Inganas Semi-sequential assay for detection of an analyte in a sample
BRPI1014089A2 (pt) 2009-04-02 2016-04-19 Roche Glycart Ag anticorpos multiespecíficos que compreendem anticorpos de comprimento completo e fragmentos fab de cadeia simples
PT2417156E (pt) 2009-04-07 2015-04-29 Roche Glycart Ag Anticorpos trivalentes, biespecíficos
SG176219A1 (en) 2009-05-27 2011-12-29 Hoffmann La Roche Tri- or tetraspecific antibodies
US9676845B2 (en) 2009-06-16 2017-06-13 Hoffmann-La Roche, Inc. Bispecific antigen binding proteins
US8703132B2 (en) 2009-06-18 2014-04-22 Hoffmann-La Roche, Inc. Bispecific, tetravalent antigen binding proteins
WO2011048043A1 (en) * 2009-10-19 2011-04-28 F. Hoffmann-La Roche Ag NON-CROSS-REACTIVE ANTI IgG ANTIBODIES
CN102207504A (zh) * 2011-03-23 2011-10-05 北京华创远航科技有限公司 一种酶联检测试剂盒及其制备方法
CN104040350B (zh) 2011-12-19 2016-05-18 弗·哈夫曼-拉罗切有限公司 用于检测多特异性结合物的游离结合搭档的方法
KR20140128314A (ko) 2012-02-01 2014-11-05 에프. 호프만-라 로슈 아게 다중특이적 결합제의 결합 파트너 검출 방법
US20130231462A1 (en) * 2012-02-27 2013-09-05 Bio-Rad Laboratories, Inc. Anti-immune complex antibodies
EP2872893B1 (en) 2012-07-13 2017-03-29 F. Hoffmann-La Roche AG Method for the detection of a multispecific antibody

Also Published As

Publication number Publication date
WO2013113663A1 (en) 2013-08-08
MX2014008762A (es) 2014-08-27
RU2014133701A (ru) 2016-03-27
CN106443016B (zh) 2019-08-13
JP2019113564A (ja) 2019-07-11
MX349661B (es) 2017-08-08
BR112014017630A2 (cg-RX-API-DMAC7.html) 2017-06-20
CA2859268A1 (en) 2013-08-08
KR20140128314A (ko) 2014-11-05
JP6678792B2 (ja) 2020-04-08
US20210055304A1 (en) 2021-02-25
JP6502441B2 (ja) 2019-04-17
HK1202921A1 (en) 2015-10-09
JP2017223710A (ja) 2017-12-21
JP2015507193A (ja) 2015-03-05
EP2810074A1 (en) 2014-12-10
US20140342382A1 (en) 2014-11-20
CN104105966A (zh) 2014-10-15
RU2620563C2 (ru) 2017-05-26
CN104105966B (zh) 2016-10-26
US9945869B2 (en) 2018-04-17
EP2810074B1 (en) 2017-08-23
CN106443016A (zh) 2017-02-22
US20180328942A1 (en) 2018-11-15
US10761097B2 (en) 2020-09-01

Similar Documents

Publication Publication Date Title
MX349661B (es) Metodo para la deteccion de una molecula de union de un enlazador multiespecifico.
BR112014008382A2 (pt) anticorpo especificamente ligando a epítope no domínio sema do c-met
BRPI0906060A2 (pt) anticorpos isolados, métodos de preparo de um anticorpo anti-clostridium difficile, composição e método para a detecção da presença de um esporo de clostridium difficile em uma amostra
MX349003B (es) Metodo para la deteccion del asociado de union libre de un aglutinante multiespecifico.
DK2890717T3 (da) Diagnostiske assays og kits til detektering af folatreceptor 1
BR112016029634A2 (pt) kit, dispositivo e método para a detecção de câncer de fígado
BR112013021666A2 (pt) detecção de capacitância em ensaio eletroquímico com compensação de tempo de amostragem aprimorada
BR112014014077A2 (pt) método para realizar uma determinação quantitativa e/ou qualitativa de finos catalíticos em óleo combustível, e, sistema apropriado para determinar finos catalíticos em um óleo combustível
EA201590027A1 (ru) Способы детекции заболеваний или состояний
BR112014025384A8 (pt) método e sistema para executar ensaio automatizado e métodos para executar teste reflexivo em vários exemplares
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
BR112016007106A2 (pt) dispositivo e método de teste de gravidez melhorado
EP2698381A4 (en) ANTIBODIES, KIT AND METHOD FOR DETERMINING AMYLOID PEPTIDES
BR112014002616A2 (pt) método para detectar cãncer pancreático e reagente ou kit para detectar câncer pancreático
BR112014018831A2 (pt) método para otimizar sensibilidade e/ou seletividade de um sensor para um ou mais analitos, método para formar um sensor para um ou mais analitos, kit para a detecção de um ou mais analitos, método de identificação de um aptâmero, composição de matéria e aptâmeros.
BR112014012590A8 (pt) Anticorpos anti-cd98 e métodos de uso dos mesmos
MX340453B (es) Biomarcadores para cancer de pulmon.
BR112012021590A2 (pt) detecção de capacitância em ensaio eletroquímico
EP3933406A3 (en) Antibodies to risperidone and use thereof
BR112018007842A2 (pt) imunoensaio para a detecção de cininogênio clivado de alto peso molecular, método, anticorpo isolado, kit para detectar um cininogênio de alto peso molecular clivado (hmwk)
RU2015104737A (ru) Способ обнаружения мультиспецифического связывающего агента
EP2599865A4 (en) MONOCLONAL ANTI-FDP ANTIBODY, FDP MEASURING REAGENT AND REAGENT KIT THEREFOR, AND FDP MEASUREMENT PROCEDURES
BR112017021186A2 (pt) ?método para detectar a presença de bactérias produtoras de beta-lactamase?
EP2554673A4 (en) NEW MONOCLONAL ANTIBODY AND IMMUNASSAY PROCESS FOR D-DIMERE
BR112014031958A2 (pt) bag3 como marcador de tecido e soro bioquímico

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2551 DE 26-11-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.